Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 3, 2004, Pages 358-362

  Takahashi, Yuji ^a   Poteser, Michael ^a   Negoro, Munetaka ^a   Wakabayashi, Ichiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase; Diabetes mellitus; Lipopolysaccharide; Prostaglandins; Protein induction; Vascular smooth muscle

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOHEXIMIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDOMETACIN; PROSTACYCLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; PROTEIN INDUCTION; RAT; STREPTOZOCIN DIABETES; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LIPOPOLYSACCHARIDES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR;

EID: 1642315519     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0853-x     Document Type: Article

References (16)

1. Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA (1997) Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol 121:125-133
2. Chandler DB, Fulmer JD (1987) Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages. J Immunol 139:893-898
3. Chandler DB, Fuller WC, Jackson RM, Fulmer JD (1986) Fractionation of rat alveolar macrophages by isopycnic centrifugation: morphological, cytochemical, biochemical, and functional properties. J Leukoc Biol 39:371-383
4. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307:361-368
5. Halushka PV, Mayfield R, Colwell JA (1985) Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism 34(Suppl 1): 32-36
6. Isobe H, Okajima K, Uchiba M, Harada N, Okabe H (2002) Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats. Blood 99: 1638-1645
7. Jeremy JY, Mikhailidis DP, Dandona P (1983) Simulating the diabetic environment modifies in vitro prostacyclin synthesis. Diabetes 32:217-221
8. Lee SH, Woo HG, Baik EJ, Moon CH (2000) High glucose enhances IL-1β-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells. Life Sci 68:57-67
9. Liu SF, Newton R, Evans TW, Barnes PJ (1996) Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci 90:301-306
10. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
11. Myers TO, Messina EJ, Rodrigues AM, Gerritsen ME (1985) Altered aortic and cremaster muscle prostaglandin synthesis in diabetic rats. Am J Physiol 249:E374-E379
12. Pozzilli P, Leslie RD (1994) Infections and diabetes: mechanisms and prospects for prevention. Diabet Med 11:935-941
13. Takahashi Y, Negoro M, Wakabayashi I (2003) Decreased modulation by lipopolysaccharide of aortic smooth muscle contractility in streptozotocin- induced hyperglycemic rats. J Cardiovasc Pharmacol 41:162-170
14. Vane JR, Bakhle YS, Bolting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120
15. Wang P, Zhou M, Cioffi WG, Bland KI, Ba ZF, Chaudry IH (2000) Is prostacyclin responsible for producing the hyperdynamic response during early sepsis? Crit Care Med 28:1534-1539
16. Wenzel RP (1988) The mortality of hospital-acquired bloodstream infections: need for a new vital statistic? Int J Epidemiol 17: 225-227